Skip to main content
  •   

    Episode 327: Loss to Follow-Up in Diabetic Retinopathy and Academic Advancement with Dr. Lisa Schocket

    Straight from the Cutter’s Mouth
    26:30
    Retina/Vitreous
    CME 0.5 General AMA PRA Category 1 Credits™
    Add to My Bookmarks

    Dr. Lisa Schocket joins to discuss loss to follow-up in diabetic retinopathy and potential future trials and solutions, as well as developing an academic career.

    Relevant Financial Disclosures:
    Dr. Sridhar is a consultant for Alcon, Allergan, Dorc, Genentech, and Regeneron.

    CME Information

    Release: January 13, 2022; expires January 13, 2025

    Reviewers: Jessica D. Randolph, MD

    Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.

    Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.

    Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.

    Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.